Your browser doesn't support javascript.
loading
Tumor-Promoting Activity and Proteomic Profiling of Cisplatin/Oxaliplatin-Derived DAMPs in Cholangiocarcinoma Cells.
Songjang, Worawat; Nensat, Chatchai; Nernpermpisooth, Nitirut; Seenak, Porrnthanate; Pankhong, Panyupa; Jumroon, Noppadon; Kumphune, Sarawut; Jiraviriyakul, Arunya.
Affiliation
  • Songjang W; Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Nensat C; Integrative Biomedical Research Unit (IBRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Nernpermpisooth N; Chulabhorn International College of Medicine, Thammasat University, Pathum Thani 12120, Thailand.
  • Seenak P; Integrative Biomedical Research Unit (IBRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Pankhong P; Department of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Jumroon N; Integrative Biomedical Research Unit (IBRU), Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Kumphune S; Department of Cardio-Thoracic Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
  • Jiraviriyakul A; Department of Medical Technology, Faculty of Allied Health Sciences, Naresuan University, Phitsanulok 65000, Thailand.
Int J Mol Sci ; 23(18)2022 Sep 11.
Article in En | MEDLINE | ID: mdl-36142453
Subject(s)
Key words
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / HMGB1 Protein / Antineoplastic Agents Limits: Humans Language: En Year: 2022 Type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Cholangiocarcinoma / HMGB1 Protein / Antineoplastic Agents Limits: Humans Language: En Year: 2022 Type: Article